• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组内毒素中和蛋白对大肠杆菌败血症大鼠模型进行早期和晚期治疗的比较。

Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.

作者信息

Weiner D L, Kuppermann N, Saladino R A, Thompson C M, Novitsky T J, Siber G R, Fleisher G R

机构信息

Department of Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Crit Care Med. 1996 Sep;24(9):1514-7. doi: 10.1097/00003246-199609000-00014.

DOI:10.1097/00003246-199609000-00014
PMID:8797624
Abstract

OBJECTIVE

To test the efficacy of a recombinant endotoxin neutralizing protein as compared with saline in rats with Escherichia coli sepsis.

DESIGN

Prospective, controlled animal trial.

SETTING

Hospital animal research laboratory.

SUBJECTS

Male Wistar rats challenged with intraperitoneal E. coli, O18ac K1, and treated 1 hr later with ceftriaxone and gentamicin.

INTERVENTIONS

Recombinant endotoxin neutralizing protein, 50 mg/kg, was administered to rats 1, 2, or 3 hrs after E. coli challenge; saline was administered to control animals.

MEASUREMENTS AND MAIN RESULTS

Quantitative bacteremia, 1 hr after challenge and before antibiotic administration, was not significantly different between treatment groups (range geometric mean 451 to 621 colony-forming units [cfu]/mL). The endotoxin concentration, measured immediately before recombinant endotoxin neutralizing protein administration, was significantly higher in animals sampled and treated at 2 hrs (geometric mean 260 EU/mL; 95% confidence interval 140 to 480 EU/mL), or 3 hrs (geometric mean 697 EU/mL; 95% confidence interval 307 to 1585 EU/mL) after E. coli challenge, compared with animals sampled and treated at 1 hr (geometric mean 17 EU/mL; 95% confidence interval 7 to 69 EU/ mL). Survival rate was significantly greater in rats treated with recombinant endotoxin neutralizing protein at 1 hr (23/27; p < .001) or 2 hrs (8/30; p < .01) after E. coli challenge than in controls (1/32).

CONCLUSION

Administration of recombinant endotoxin neutralizing protein delayed up to 2 hrs after challenge with E. coli improves survival in antibiotic-treated rats with Gram-negative sepsis.

摘要

目的

在患有大肠杆菌败血症的大鼠中,测试重组内毒素中和蛋白与生理盐水相比的疗效。

设计

前瞻性对照动物试验。

地点

医院动物研究实验室。

对象

雄性Wistar大鼠,经腹腔注射大肠杆菌O18ac K1进行攻击,1小时后用头孢曲松和庆大霉素治疗。

干预措施

在大肠杆菌攻击后1、2或3小时,给大鼠注射50mg/kg重组内毒素中和蛋白;给对照动物注射生理盐水。

测量指标及主要结果

攻击后1小时且在给予抗生素之前,各治疗组间的定量菌血症无显著差异(几何平均值范围为451至621菌落形成单位[cfu]/mL)。在给予重组内毒素中和蛋白之前立即测量的内毒素浓度,在大肠杆菌攻击后2小时(几何平均值260 EU/mL;95%置信区间140至480 EU/mL)或3小时(几何平均值697 EU/mL;95%置信区间307至1585 EU/mL)采样并治疗的动物中,显著高于在1小时(几何平均值17 EU/mL;95%置信区间7至69 EU/mL)采样并治疗的动物。在大肠杆菌攻击后1小时(23/27;p<.001)或2小时(8/30;p<.01)接受重组内毒素中和蛋白治疗的大鼠的存活率显著高于对照组(1/32)。

结论

在大肠杆菌攻击后长达2小时给予重组内毒素中和蛋白,可提高接受抗生素治疗的革兰氏阴性败血症大鼠的存活率。

相似文献

1
Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.重组内毒素中和蛋白对大肠杆菌败血症大鼠模型进行早期和晚期治疗的比较。
Crit Care Med. 1996 Sep;24(9):1514-7. doi: 10.1097/00003246-199609000-00014.
2
High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
Crit Care Med. 1996 Jul;24(7):1203-7. doi: 10.1097/00003246-199607000-00023.
3
Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
Crit Care Med. 1995 Jan;23(1):92-8. doi: 10.1097/00003246-199501000-00017.
4
Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
J Infect Dis. 1994 Sep;170(3):630-5. doi: 10.1093/infdis/170.3.630.
5
A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .杀菌/通透性增加蛋白变体与重组内毒素中和蛋白治疗大鼠大肠杆菌败血症的比较
Crit Care Med. 1997 Jan;25(1):101-5. doi: 10.1097/00003246-199701000-00020.
6
Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.重组内毒素中和蛋白对大肠杆菌败血症家兔的疗效
Circ Shock. 1994 Feb;42(2):104-10.
7
Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.重组内毒素中和蛋白对兔内毒素休克的影响。
Crit Care Med. 1994 Aug;22(8):1211-8. doi: 10.1097/00003246-199408000-00003.
8
Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.鼠抗肿瘤坏死因子单克隆抗体在兔大肠杆菌败血症中的预防性和治疗性应用失败。
Crit Care Med. 1995 Sep;23(9):1512-8. doi: 10.1097/00003246-199509000-00011.
9
Impact of different classes antimicrobial agents on plasma endotoxin activity.不同种类抗菌药物对血浆内毒素活性的影响。
Arch Surg. 1996 Feb;131(2):192-9. doi: 10.1001/archsurg.1996.01430140082022.
10
Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.抗生素类别在实验性革兰氏阴性菌败血症治疗期间内毒素释放速率中的作用。
J Infect Dis. 1985 Jun;151(6):1012-8. doi: 10.1093/infdis/151.6.1012.